← All trials
NCT05743335
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 20, 2023
- Primary completion
- Sep 6, 2024
- Completion date
- Oct 4, 2024
- First posted
- Feb 24, 2023
- Last posted
- Mar 17, 2023
- Enrollment
- 262
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Immorna Biotherapeutics, Inc.Lead sponsor
- ICONCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.